ARMOUR RESIDENTIAL REIT INC
ARRNYSETrading Snapshot
- Day Range
- $12.64 β $12.84
- 52-Week Range
- $12.28 β $19.31
- Volume (shares)
- 3,432,208
- Avg Volume (shares)
- β
- Shares Outstanding
- 148.4M
- Next Earnings
- 2027-02-16
Fundamentals Snapshot
- Annual Revenue
- $1.31B
- Last Q Revenue
- $274M
- P/E Ratio
- β
- P/S Ratio
- 2.5x
- EPS (TTM)
- $0.06
- Dividend Yield
- 20.09%
- Dilution (1yr)
- +115.2%
ARMOUR RESIDENTIAL REIT INC
ARR
StockOtter Β· stockotter.spaceAbout ARMOUR RESIDENTIAL REIT INC
ARMOUR Residential REIT, Inc. (ARR), founded in 2008 and based in Vero Beach, Florida, primarily allocates its capital to residential mortgage-backed securities (MBS) within the United States. Its investment holdings predominantly comprise MBS that are either issued or guaranteed by U.S. Government-sponsored entities (GSEs) and the Government National Mortgage Association (GNMA. These securities are underpinned by various home loans, including fixed-rate, hybrid adjustable-rate, and adjustable-rate mortgages. The company's portfolio also encompasses unsecured debt instruments and bonds from GSEs, U.S. Treasury securities, and money market funds. Furthermore, ARR invests in other residential mortgage-backed securities where the principal and interest payments lack a guarantee from a GSE or other government agency. As a Real Estate Investment Trust (REIT) under the Internal Revenue Code, the company benefits from an exemption from corporate income tax on the portion of its net earnings that is distributed to its shareholders.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
ARMOUR Residential: 3 Key Takeaways for Long-Term Investors
ARMOUR Residential reported a Q3 GAAP net loss of $327 million. Quarter-end book value declined 17% to $14.55 per common share.
Armour Residential REIT: A Discounted Recovery Play Earns A Cautious Buy
ARMOUR Residential REIT is rated a cautious BUY at $12.88, trading at a 12% discount to estimated book value and offering a 22.4% yield. My base case expects a 15%β25% total return over 12 months if mortgage spreads stab
ArriVent BioPharma's ARR-217 Shows 44.8% Response Rate in Colorectal Cancer Study
ArriVent BioPharma NASDAQ: AVBP presented Phase I data for ARR-217, its CDH17-targeting antibody-drug conjugate, or ADC, in heavily pretreated metastatic colorectal cancer patients during a virtual webinar following an E
Armour Residential REIT: Sidelined Again As A High-Yield Idea With MBS Volatility
ARMOUR Residential REIT offers a yield above 22% but remains a neutral-rated hold due to persistent headwinds. ARR underperforms key benchmarks and peers, with weak momentum, elevated leverage, and negative EPS growth ex
REITs Rebound As Earnings Deliver
U.S. markets remained unsettled as cracks emerged in the AI investment boom, while another oil-price surge complicated the inflation outlook ahead of Wednesday's Fed decision. Treasury yields fell for a third straight we
RYBREVANT FASPROβ’ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
RYBREVANT FASPROΓ’ΒΒ’ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced he